Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Testing effectiveness (Phase 2)Study completedNCT06511895
What this trial is testing

AZD4205 in Relapsed or Refractory Peripheral T Cell Lymphoma (JACKPOT27)

Who this might be right for
Peripheral T Cell Lymphoma
Dizal Pharmaceuticals 57
Testing effectiveness (Phase 2)Looking for participantsNCT06151106
What this trial is testing

Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T Cell LymphomaRelapsed Peripheral T-Cell LymphomaRefractory T-Cell Lymphoma
The First Affiliated Hospital of Xiamen University 33
Testing effectiveness (Phase 2)Looking for participantsNCT05833724
What this trial is testing

Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)

Who this might be right for
Relapsed or Refractory Peripheral T-cell Lymphoma
Great Novel Therapeutics Biotech & Medicals Corporation 33
Very early researchUnknownNCT04696705
What this trial is testing

Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Peripheral T Cell Lymphoma (PTCL)
Institute of Hematology & Blood Diseases Hospital, China 10
Testing effectiveness (Phase 2)Study completedNCT03496779
What this trial is testing

Study of Brentuximab Vedotin in Patients With R/R PTCL Treated With Gemcitabine

Who this might be right for
Refractory Peripheral T-Cell LymphomaRelapsed Peripheral T-Cell Lymphoma
The Lymphoma Academic Research Organisation 71
Testing effectiveness (Phase 2)Looking for participantsNCT07022964
What this trial is testing

CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas

Who this might be right for
T-Cell Non-Hodgkin LymphomaT-cell Lymphoma (PTCL and CTCL)
Beijing GoBroad Hospital 36
Early research (Phase 1)Looking for participantsNCT07143929
What this trial is testing

To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL

Who this might be right for
CD7 Positive R/R PTCL
Peking University People's Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT06925464
What this trial is testing

CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas

Who this might be right for
T-Cell Non-Hodgkin LymphomaT-cell Lymphoma (PTCL and CTCL)
Beijing GoBroad Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT06874946
What this trial is testing

Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL

Who this might be right for
Precursor T-Cell Lymphoblastic Leukemia-LymphomaT - Cell LymphomaPTCL
Peking University People's Hospital 30
Early research (Phase 1)Active Not RecruitingNCT04526834
What this trial is testing

Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaPeripheral T Cell LymphomaExtranodal NK/T-cell Lymphoma+2 more
Tessa Therapeutics 21
Testing effectiveness (Phase 2)Ended earlyNCT05883449
What this trial is testing

Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaPeripheral T Cell Lymphoma
Affimed GmbH 25
Testing effectiveness (Phase 2)Looking for participantsNCT07372352
What this trial is testing

Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL

Who this might be right for
Peripheral T Cells Lymphoma (PTCL)
The First Affiliated Hospital of Soochow University 26
Testing effectiveness (Phase 2)UnknownNCT05559008
What this trial is testing

A Umbrella Study in R/R PTCL Guided by Molecular Subtypes

Who this might be right for
Peripheral T Cell Lymphoma
Ruijin Hospital 116
Testing effectiveness (Phase 2)Looking for participantsNCT07018752
What this trial is testing

A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas

Who this might be right for
Peripheral T Cells Lymphoma (PTCL)
The Lymphoma Academic Research Organisation 49
Testing effectiveness (Phase 2)Looking for participantsNCT06909877
What this trial is testing

Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma

Who this might be right for
Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
Haihe Biopharma Co., Ltd. 100
Not applicableUnknownNCT06211881
What this trial is testing

Chi-GVM Regimen for the Treatment of R/R PTCL

Who this might be right for
Relapsed/Refractory Peripheral T-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 50
Early research (Phase 1)WithdrawnNCT02757248
What this trial is testing

Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL

Who this might be right for
PTCLCTCL
Anne Beaven, MD
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07180771
What this trial is testing

Bosmolisib (BR101801) in Participants With R/R PTCL.

Who this might be right for
Peripheral T Cell Lymphoma
Boryung Pharmaceutical Co., Ltd 44
Testing effectiveness (Phase 2)UnknownNCT05274997
What this trial is testing

A Phase II Study of Linperlisib (YY-20394) in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma

Who this might be right for
Peripheral T/NK Cell Lymphoma (R/R PTCL)
Shanghai YingLi Pharmaceutical Co. Ltd. 97
Large-scale testing (Phase 3)Looking for participantsNCT07234162
What this trial is testing

Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)

Who this might be right for
Peripheral T-cell Lymphoma
Dizal Pharmaceuticals 218
Next Page